Do buprenorphine doses and ratios matter in medication assisted treatment adherence?

• Main Authors: Kevin Kavanagh, PharmD, BCPP (Author), Kimberly Tallian, PharmD, APh, BCPP (Author), Joe A. Sepulveda, MD, FAPA, FASAM (Author), Sarah Rojas, MD (Author), Shedrick Martin, PharmD, BCPP (Author), Harminder Sikand, PharmD (Author)
• 格式: 圖書
• 出版: American Association of Psychiatric Pharmacists, 2023-08-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Introduction: Buprenorphine (BUP), generally prescribed as buprenorphine/naloxone, is a key component of medication-assisted treatment (MAT) to manage opioid use disorder. Studies suggest higher doses of BUP increase treatment adherence. Routine urine drug screens (UDS) assist in monitoring MAT adhe...